miRNAs orchestration of adrenocortical carcinoma-Particular emphasis on diagnosis, progression and drug resistance
WA El-Dakroury, HM Midan, AI Abulsoud… - … -Research and Practice, 2023 - Elsevier
Adrenocortical carcinoma (ACC) is an uncommon aggressive endocrine malignancy that is
nonetheless associated with significant mortality and morbidity rates because of endocrine …
nonetheless associated with significant mortality and morbidity rates because of endocrine …
miRNAs orchestration of adrenocortical carcinoma-Particular emphasis on diagnosis, progression and drug resistance
WA El-Dakroury, HM Midan, AI Abulsoud… - Pathology, research … - pubmed.ncbi.nlm.nih.gov
Adrenocortical carcinoma (ACC) is an uncommon aggressive endocrine malignancy that is
nonetheless associated with significant mortality and morbidity rates because of endocrine …
nonetheless associated with significant mortality and morbidity rates because of endocrine …
miRNAs orchestration of adrenocortical carcinoma-Particular emphasis on diagnosis, progression and drug resistance.
WA El-Dakroury, HM Midan, AI Abulsoud… - Pathology, Research …, 2023 - europepmc.org
Adrenocortical carcinoma (ACC) is an uncommon aggressive endocrine malignancy that is
nonetheless associated with significant mortality and morbidity rates because of endocrine …
nonetheless associated with significant mortality and morbidity rates because of endocrine …